shire map
Select a

Shire Global

Better Health, Brighter Future


Shire to participate at two upcoming investor conferences

Lexington, MA, USA – September 7, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer, will present at the Bank of America Merrill Lynch Global Healthcare Conference 2017 on September 14, 2017 at 1:45 p.m. BST (8:45 a.m. EDT) and Jeff Poulton, Chief Financial Officer will participate at the Morgan Stanley Global Healthcare Conference on September 12, 2017 at 3:30 p.m. EDT (8:30 p.m. BST).

The live audio webcasts of both events will be available on Shire's Investor website at Subsequently, a replay of both events will be available on this same website

For further information please contact:

Investor Relations   
Ian 781 482 9018
Robert Coates 1256 894874


About Shire

Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.


Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE